These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 18468784)

  • 1. Multitargeted therapy of cancer by ellagitannins.
    Heber D
    Cancer Lett; 2008 Oct; 269(2):262-8. PubMed ID: 18468784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland.
    Seeram NP; Aronson WJ; Zhang Y; Henning SM; Moro A; Lee RP; Sartippour M; Harris DM; Rettig M; Suchard MA; Pantuck AJ; Belldegrun A; Heber D
    J Agric Food Chem; 2007 Sep; 55(19):7732-7. PubMed ID: 17722872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice.
    Cerdá B; Llorach R; Cerón JJ; Espín JC; Tomás-Barberán FA
    Eur J Nutr; 2003 Jan; 42(1):18-28. PubMed ID: 12594538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and antioxidant activity of a pomegranate ellagitannin-enriched polyphenol dietary supplement in overweight individuals with increased waist size.
    Heber D; Seeram NP; Wyatt H; Henning SM; Zhang Y; Ogden LG; Dreher M; Hill JO
    J Agric Food Chem; 2007 Nov; 55(24):10050-4. PubMed ID: 17966977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabrication of nanoparticles using partially purified pomegranate ellagitannins and gelatin and their apoptotic effects.
    Li Z; Percival SS; Bonard S; Gu L
    Mol Nutr Food Res; 2011 Jul; 55(7):1096-103. PubMed ID: 21374799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells.
    Adams LS; Seeram NP; Aggarwal BB; Takada Y; Sand D; Heber D
    J Agric Food Chem; 2006 Feb; 54(3):980-5. PubMed ID: 16448212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ellagitannins, ellagic acid and vascular health.
    Larrosa M; García-Conesa MT; Espín JC; Tomás-Barberán FA
    Mol Aspects Med; 2010 Dec; 31(6):513-39. PubMed ID: 20837052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans.
    Cerdá B; Espín JC; Parra S; Martínez P; Tomás-Barberán FA
    Eur J Nutr; 2004 Aug; 43(4):205-20. PubMed ID: 15309440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urolithins, intestinal microbial metabolites of Pomegranate ellagitannins, exhibit potent antioxidant activity in a cell-based assay.
    Bialonska D; Kasimsetty SG; Khan SI; Ferreira D
    J Agric Food Chem; 2009 Nov; 57(21):10181-6. PubMed ID: 19824638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colon cancer chemopreventive activities of pomegranate ellagitannins and urolithins.
    Kasimsetty SG; Bialonska D; Reddy MK; Ma G; Khan SI; Ferreira D
    J Agric Food Chem; 2010 Feb; 58(4):2180-7. PubMed ID: 20112993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urolithins, gut microbiota-derived metabolites of ellagitannins, inhibit LPS-induced inflammation in RAW 264.7 murine macrophages.
    Piwowarski JP; Kiss AK; Granica S; Moeslinger T
    Mol Nutr Food Res; 2015 Nov; 59(11):2168-77. PubMed ID: 26202092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic.
    Cerdá B; Cerón JJ; Tomás-Barberán FA; Espín JC
    J Agric Food Chem; 2003 May; 51(11):3493-501. PubMed ID: 12744688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo.
    Sartippour MR; Seeram NP; Rao JY; Moro A; Harris DM; Henning SM; Firouzi A; Rettig MB; Aronson WJ; Pantuck AJ; Heber D
    Int J Oncol; 2008 Feb; 32(2):475-80. PubMed ID: 18202771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patients.
    Nuñez-Sánchez MA; García-Villalba R; Monedero-Saiz T; García-Talavera NV; Gómez-Sánchez MB; Sánchez-Álvarez C; García-Albert AM; Rodríguez-Gil FJ; Ruiz-Marín M; Pastor-Quirante FA; Martínez-Díaz F; Yáñez-Gascón MJ; González-Sarrías A; Tomás-Barberán FA; Espín JC
    Mol Nutr Food Res; 2014 Jun; 58(6):1199-211. PubMed ID: 24532260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of pomegranate (Punica granatum L.) byproducts and ellagitannins on the growth of human gut bacteria.
    Bialonska D; Kasimsetty SG; Schrader KK; Ferreira D
    J Agric Food Chem; 2009 Sep; 57(18):8344-9. PubMed ID: 19705832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of urinary and intestinal bacterial metabolites of ellagitannin geraniin in rats.
    Ito H; Iguchi A; Hatano T
    J Agric Food Chem; 2008 Jan; 56(2):393-400. PubMed ID: 18163562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UV and MS identification of Urolithins and Nasutins, the bioavailable metabolites of ellagitannins and ellagic acid in different mammals.
    González-Barrio R; Truchado P; Ito H; Espín JC; Tomás-Barberán FA
    J Agric Food Chem; 2011 Feb; 59(4):1152-62. PubMed ID: 21265540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of gut microbiota-derived ellagitannins' metabolites urolithins on pro-inflammatory activities of human neutrophils.
    Piwowarski JP; Granica S; Kiss AK
    Planta Med; 2014 Jul; 80(11):887-95. PubMed ID: 24995502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new method of standartization of health-promoting pomegranate fruit (Punica granatum) extract.
    Jimenez Del Rio M; Ramazanov A; Sikorski S; Ramazanov Z; Chkhikvishvili I
    Georgian Med News; 2006 Nov; (140):70-7. PubMed ID: 17179594
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.